Neuroprotective Actions of Coenzyme Q10 in Parkinson's Disease
Authors:
- M KheradpezhouMKM Kheradpezhou
- S ShavaliSSS Shavali
- H.EL RefaeyHRH.EL Refaey
- J EkenJEJ Eken
- C HagenCHC Hagen
- M EbadiMEM Ebadi
- 1 January 2004
- book chapter
- Published by Elsevier
- Vol. 382, 488-509
Abstract
No abstract availableThis publication has 57 references indexed in Scilit:
- Metallothionein Attenuates 3-Morpholinosydnonimine (SIN-1)-Induced Oxidative Stress in Dopaminergic NeuronsAntioxidants & Redox Signaling, 2003
- Mitochondrial Nitric Oxide Synthase, Oxidative Stress and ApoptosisNeurosignals, 2001
- MPP+ Increases the Vulnerability to Oxidative Stress Rather Than Directly Mediating Oxidative Damage in Human Neuroblastoma CellsExperimental Neurology, 2000
- (−)‐Deprenyl Protects Human Dopaminergic Neuroblastoma SH‐SY5Y Cells from Apoptosis Induced by Peroxynitrite and Nitric OxideJournal of Neurochemistry, 1998
- Peroxynitrite‐Mediated Inhibition of DOPA Synthesis in PC12 CellsJournal of Neurochemistry, 1995
- Amyotrophic lateral sclerosis: Recent insights from genetics and transgenic miceCell, 1995
- Oxygen Free Radicals and Neurodegeneration in Parkinson's Disease: A Role for Nitric OxideaAnnals of the New York Academy of Sciences, 1994
- Peroxynitrite versus Hydroxyl Radical: The Role of Nitric Oxide in Superoxide‐Dependent Cerebral InjuryaAnnals of the New York Academy of Sciences, 1994
- Selective MAO-A and B inhibitors, radical scavengers and nitric oxide synthase inhibitors in Parkinson's deseaseLife Sciences, 1994
- Biochemistry of Nitric Oxide and Its Redox-Activated FormsScience, 1992